<DOC>
	<DOCNO>NCT01804647</DOCNO>
	<brief_summary>This study intend explore evolution MSRV expression analyze level MSRV transcript blood , well level MSRV-Env protein serum MS patient . The study conduct one year four cohort patient different form MS ( remitting-relapsing MS i.e . RRMS , primary-progressive MS i.e . PPMS secondary-progressive MS i.e . SPMS ) clinically isolated syndrome ( CIS ) patient suffer single clinical event comply diagnosis criterion definite MS . The MSRV RNA MSRV-Env protein level correlate clinical evolution patient reverse transcriptase activity , inflammatory marker assess cytokine level . A control group healthy subject include ( study , GN-E-003 , perform parallel part another dedicate protocol ) .</brief_summary>
	<brief_title>Longitudinal Therapeutically Non-interventional Study MSRV-Env Burden Patients With Multiple Sclerosis Disease</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Signature informed consent ; Male female 18 60 year age ; Patients PPMS ( Revised McDonald criterion 2010 ) patient SPMS CIS patient RRMS ( Revised McDonald criterion 2010 ) ideally without IFN beta therapy T0 visit RRMS patient . Positive serology hepatitis B C HIV ; Acute infection inclusion ; Severe psychiatric disorder ; Autoimmune disease MS ; Pregnancy breastfeeding ; Heavy smoker i.e . 10 cigarette per day ; History alcohol drug abuse last 3 year ; Participation clinical trial ( within last 3 month ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Multiple sclerosis ( MS )</keyword>
	<keyword>Relapsing-Remitting MS</keyword>
	<keyword>Primary progressive MS</keyword>
	<keyword>Secondary progressive MS</keyword>
	<keyword>Clinically Isolated Syndrome ( CIS )</keyword>
	<keyword>Multiple Sclerosis associate RetroVirus ( MSRV )</keyword>
	<keyword>MSRV envelop protein ( MSRV-Env )</keyword>
</DOC>